Different patterns of p16INK4a immunohistochemical expression and their biological implications in laryngeal squamous cell carcinoma

Rom J Morphol Embryol. 2020 Jul-Sep;61(3):697-706. doi: 10.47162/RJME.61.3.08.

Abstract

Introduction: p16INK4a immunohistochemistry (IHC) is widely used to facilitate the diagnosis of human papillomavirus (HPV)-associated neoplasia, when ≥70% of cells show strong nuclear and cytoplasmic positivity. In this study, we aim to compare partial expression patterns that do not fulfill the above criteria and seek biological implications in laryngeal squamous cell carcinoma (LSCC).

Materials and methods: p16INK4a IHC staining was conducted on representative sections of archived tissue from 88 LSCCs. Immunoreactivity was described based on four parameters: intracellular localization of immunostaining, intensity of immunostaining, distribution pattern and percentage of positive cells.

Results: Six patterns of p16INK4a immunoexpression were observed and defined as: strong diffuse (strong immunostaining, expression in cytoplasm and nucleus in >70% of tumor cells), weak diffuse (moderate or weak immunostaining, expression in cytoplasm in >70% of tumor cells), marginal (strong cytoplasmic immunostaining, limited to the periphery of tumor islets), strong scattered (strong immunostaining, expression in cytoplasm and nucleus in <50% of tumor cells), weak scattered (moderate or weak immunostaining, expression in cytoplasm in <50% of tumor cells), negative (no expression). The pN stage of the patients was associated with p16INK4a immunoexpression patterns, the marginal pattern was only found in the pN0-Nx stages, while the weak diffuse pattern was more frequently observed in pN2-N3 stages.

Conclusions: Partial immunostaining with architecturally distinct p16INK4a immunoexpression patterns may prove significant in stratifying characteristic clinicopathological subgroups among LSCC. Our observations may support the hypothesis that p16INK4a has different roles in different subcellular locations, with tumorigenic molecular pathways unrelated to HPV infection.

MeSH terms

  • Biomarkers, Tumor
  • Carcinoma, Squamous Cell*
  • Cyclin-Dependent Kinase Inhibitor p16
  • Female
  • Head and Neck Neoplasms*
  • Humans
  • Papillomaviridae
  • Squamous Cell Carcinoma of Head and Neck
  • Uterine Cervical Neoplasms*

Substances

  • Biomarkers, Tumor
  • Cyclin-Dependent Kinase Inhibitor p16